AR013096A1 - SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME. - Google Patents

SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.

Info

Publication number
AR013096A1
AR013096A1 ARP980102925A ARP980102925A AR013096A1 AR 013096 A1 AR013096 A1 AR 013096A1 AR P980102925 A ARP980102925 A AR P980102925A AR P980102925 A ARP980102925 A AR P980102925A AR 013096 A1 AR013096 A1 AR 013096A1
Authority
AR
Argentina
Prior art keywords
tetrazol
methyl
preparation
maleic acid
tetrahidropiridina
Prior art date
Application number
ARP980102925A
Other languages
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR013096A1 publication Critical patent/AR013096A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Sal de adicion de ácido maleico de 5-(2-etil-2-H-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahdropiridina, composiciones farmacéuticas que contienen la sal deadicion ácida, el uso de las mismas para el tratamiento de trastornos causados por unmal funcionamiento de la acetilcolina (AcCh) o del sistemamuscarínico; y método de preparacion de la misma.5- (2-Ethyl-2-H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahdropyridine maleic acid addition salt, pharmaceutical compositions containing the acidic salt, use thereof for the treatment of disorders caused by a malfunction of acetylcholine (AcCh) or the muscarinic system; and method of preparation thereof.

ARP980102925A 1997-07-01 1998-06-18 SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME. AR013096A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
AR013096A1 true AR013096A1 (en) 2000-12-13

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102925A AR013096A1 (en) 1997-07-01 1998-06-18 SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.

Country Status (25)

Country Link
EP (1) EP0994869A1 (en)
JP (1) JP2002507215A (en)
KR (1) KR20010014297A (en)
CN (1) CN1261361A (en)
AR (1) AR013096A1 (en)
AU (1) AU735751B2 (en)
BG (1) BG103933A (en)
BR (1) BR9810331A (en)
CA (1) CA2293324A1 (en)
CO (1) CO4940483A1 (en)
EA (1) EA200000081A1 (en)
HU (1) HUP0002876A2 (en)
IL (1) IL133093A0 (en)
IS (1) IS5278A (en)
JO (1) JO2031B1 (en)
MA (1) MA25138A1 (en)
NO (1) NO996580D0 (en)
PE (1) PE116099A1 (en)
PL (1) PL337184A1 (en)
SK (1) SK187399A3 (en)
TN (1) TNSN98120A1 (en)
TR (1) TR199903283T2 (en)
UY (2) UY25069A1 (en)
WO (1) WO1999001448A1 (en)
ZA (1) ZA985498B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
PL326490A1 (en) * 1995-11-06 1998-09-28 Lundbeck & Co As H Treatment of traumatic brain injuries

Also Published As

Publication number Publication date
TR199903283T2 (en) 2000-06-21
UY25069A1 (en) 1998-12-21
PL337184A1 (en) 2000-08-14
BG103933A (en) 2000-07-31
AU735751B2 (en) 2001-07-12
CO4940483A1 (en) 2000-07-24
IL133093A0 (en) 2001-03-19
TNSN98120A1 (en) 2005-03-15
WO1999001448A1 (en) 1999-01-14
MA25138A1 (en) 2001-04-02
NO996580L (en) 1999-12-30
SK187399A3 (en) 2000-06-12
CN1261361A (en) 2000-07-26
JO2031B1 (en) 1999-05-15
AU8102098A (en) 1999-01-25
BR9810331A (en) 2000-09-05
PE116099A1 (en) 1999-11-23
KR20010014297A (en) 2001-02-26
JP2002507215A (en) 2002-03-05
IS5278A (en) 1999-11-30
NO996580D0 (en) 1999-12-30
CA2293324A1 (en) 1999-01-14
EP0994869A1 (en) 2000-04-26
EA200000081A1 (en) 2000-08-28
UY25177A1 (en) 2000-12-29
ZA985498B (en) 1999-01-20
HUP0002876A2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
DE69017302D1 (en) Central cholecystokinin antagonists for the treatment of psychiatric diseases.
BR9714082A (en) Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound.
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
ATE225341T1 (en) PACLITAXELE SUBSTITUTED BY THIO IN 6 POSITION
BR9714517A (en) Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds
DK0495982T3 (en) Bicyclic pyrimidine derivative, process for its preparation and pharmaceutical composition comprising this as an active ingredient
BG101118A (en) Therapeutical compounds
BR9714059A (en) S-omeprazole in a neutral form, process to prepare it, use of it, pharmaceutical composition, and process to treat a condition related to gastric acid.
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
ES2149276T3 (en) IMIDAZO (4,5-C) PIRIDIN-4-AMINAS.
PT100850A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A SYNERGY MIX OF A URICOSURIC AGENT, IN PARTICULAR, OF PROBENECID, WITH AN ANTAGONIST AGENT OF AMINOACIDES EXCITING, ESPECIALLY, A DERIVATIVE OF SUBSTITUTED CHINOXALINE AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
KR870700599A (en) Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof
FI972308A0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use
BR0009524A (en) Use of a compound, and, pharmaceutical or veterinary composition
BRPI0409884A (en) compounds, pharmaceutical compositions, method for treating or porphyxia of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
EP0974363A4 (en) Remedies for drug addiction
BR9809234A (en) Compound, pharmaceutical composition, use of a compound, processes to treat or prevent diseases of the endocrinological system, to manufacture a drug, to prepare a compound and a set, and use of it.
BRPI0409818A (en) compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
AR013096A1 (en) SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.
DK52080A (en) DEHYDROPEPTIDES PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DE3850044D1 (en) Azelastine embonate, process for its preparation and pharmaceutical preparations containing azelastine embonate as active ingredient.
NO965370L (en) Substituted chromanylsulfonyl (thio) ureas, processes for their preparation, their use in pharmaceutical compositions and pharmaceutical compositions containing the compounds
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES
DE69009765D1 (en) KYNURIC ACID DERIVATIVES, THEIR PRODUCTION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal